Stockholders’ Equity and Equity Incentive Plans (Tables)
|
6 Months Ended |
Jul. 31, 2022 |
| Stockholders' Equity Note [Abstract] |
|
| Schedule of Stock Option Activity Under Equity Incentive Plan |
A summary of stock option activity under our equity incentive plan and related information is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | Stock Options | | | Outstanding Stock Options | | Weighted- Average Exercise Price | | Weighted- Average Remaining Contractual Life (Years) | | Aggregate Intrinsic Value | | | | | | | | | | | | (in thousands, except share, life, and per share data) | | | Balance as of January 31, 2022 | 6,195,205 | | | $ | 8.08 | | | 6.0 | | $ | 905,744 | | | | Exercised | (858,055) | | | $ | 5.90 | | | | | $ | 91,811 | | | | Canceled/forfeited/expired | (83,072) | | | $ | 21.48 | | | | | | | | Outstanding as of July 31, 2022 | 5,254,078 | | | $ | 8.22 | | | 5.5 | | $ | 502,488 | | | | Vested and expected to vest as of July 31, 2022 | 5,254,078 | | | $ | 8.22 | | | 5.5 | | $ | 502,488 | | | | Exercisable as of July 31, 2022 | 4,869,691 | | | $ | 6.81 | | | 5.4 | | $ | 472,618 | | |
|
| Schedule of Restricted Stock Units (RSUs) Activity Under Equity Incentive Plan |
A summary of restricted stock unit (“RSU”) activity under our equity incentive plan and related information is as follows: | | | | | | | | | | | | | RSUs | | Unvested RSUs | | Weighted- Average Grant Date Fair Value Per Share | | Unvested as of January 31, 2022 | 5,546,366 | | | $ | 232.58 | | | Granted | 10,737,425 | | | $ | 110.99 | | | | | | | Vested | (1,906,359) | | | $ | 189.17 | | | Canceled/forfeited | (826,734) | | | $ | 173.54 | | | Unvested as of July 31, 2022 | 13,550,698 | | | $ | 145.93 | |
|
| Schedule of Stock-based Compensation Expense by Line Item |
The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended July 31, | | Six Months Ended July 31, | | 2022 | | 2021 | | 2022 | | 2021 | | | | | | | | | | (in thousands) | | Cost of revenue | $ | 37,177 | | | $ | 14,778 | | | $ | 68,327 | | | $ | 28,844 | | | Research and development | 69,701 | | | 22,917 | | | 125,452 | | | 43,736 | | | Sales and marketing | 110,161 | | | 50,856 | | | 203,956 | | | 102,668 | | | General and administrative | 38,476 | | | 13,591 | | | 67,143 | | | 25,863 | | | Total stock-based compensation expense | $ | 255,515 | | | $ | 102,142 | | | 464,878 | | | 201,111 | | | Benefit from income taxes | (54,117) | | | — | | | (97,032) | | | — | | | Total stock-based compensation expense recorded to net income | $ | 201,398 | | | $ | 102,142 | | | $ | 367,846 | | | $ | 201,111 | | | | | | | | | |
|